Sinopsis
New and exciting data presented each day during the conference and address the potential impact on current clinical practice.
Episodios
-
![Negative Pressure Wound Therapy with Instillation: Interdisciplinary Panel Recommendations - Elizabeth Ann Faust, RN and Paul J. Kim, DPM, MS]()
Negative Pressure Wound Therapy with Instillation: Interdisciplinary Panel Recommendations - Elizabeth Ann Faust, RN and Paul J. Kim, DPM, MS
11/07/2019 Duración: 01h10minThis webcast features recommendations on the use of negative pressure wound therapy with instillation (NPWTi) from an interdisciplinary panel.
-
![Navigating the Landscape of Reimbursement for Skin Substitutes - Vipul Dev, MD Jeffrey Lehrman, DPM John H. Samies, MD]()
Navigating the Landscape of Reimbursement for Skin Substitutes - Vipul Dev, MD; Jeffrey Lehrman, DPM; John H. Samies, MD
11/07/2019 Duración: 01h02minDrs. Vipul Dev, Jeffrey Lehrmann, and John H. Samies discuss best practices for navigating the reimbursement landscape for procedures involving skin substitutes.
-
![Targeting IBD: Hitting the Mark in Todays Treatment Landscape - David T. Rubin, MD]()
Targeting IBD: Hitting the Mark in Today's Treatment Landscape - David T. Rubin, MD
11/07/2019 Duración: 41minDr. David T. Rubin examines current and emerging treatment targets and agents for the management of IBD, including clinical data on new and emerging biologic therapies.
-
![Optimizing Biosimilars for Safe and Effective Management of IMIDs - Jonathan Kay, MD]()
Optimizing Biosimilars for Safe and Effective Management of IMIDs - Jonathan Kay, MD
11/07/2019 Duración: 39minLearn about the safety, efficacy, and biosimilar switching evidence base for current and emerging biosimilars in IMIDs.
-
![Psoriatic Arthritis: Novel Targets and Treatment Advances - M. Elaine Husni, MD, MPH]()
Psoriatic Arthritis: Novel Targets and Treatment Advances - M. Elaine Husni, MD, MPH
11/07/2019 Duración: 35minThis webcast discusses current treatment barriers, new and emerging agents, and guideline recommendations into comprehensive, evidence-based treatment plans for psoriatic arthritis.
-
![Raising Awareness of EGPA: Optimal Diagnostic, Therapeutic, and Team-Based Care Strategies - Anisha Dua, MD, MPH]()
Raising Awareness of EGPA: Optimal Diagnostic, Therapeutic, and Team-Based Care Strategies - Anisha Dua, MD, MPH
11/07/2019 Duración: 37minThis webcast outlines the current understanding of EGPA pathophysiology and the resultant implications for targeted therapy, and examines the clinical efficacy and safety data surrounding current and emerging targeted therapies.
-
![The Expanding Role of JAK-Inhibition in Immune-Mediated Diseases: Small Molecule, Broad Use? - Vibeke Strand, MD, MACR, FACP]()
The Expanding Role of JAK-Inhibition in Immune-Mediated Diseases: Small Molecule, Broad Use? - Vibeke Strand, MD, MACR, FACP
11/07/2019 Duración: 43minDr. Vibeke Strand discusses the mechanism of action of JAK inhibitors and examines the efficacy, safety, and adverse events associated with this class of small molecule therapeutics.
-
![Pemphigus Vulgaris: Tackling Clinical Challenges through Targeted Therapy - Erin Wei, MD]()
Pemphigus Vulgaris: Tackling Clinical Challenges through Targeted Therapy - Erin Wei, MD
11/07/2019 Duración: 25minLearn about the latest clinical evidence surrounding new and emerging PV-targeted therapies with respect to mechanisms of action, efficacy, and safety for informed therapeutic selection.
-
![Giant Cell Arteritis: Breaking Down Barriers to Optimal Management - John Stone, MD, MPH]()
Giant Cell Arteritis: Breaking Down Barriers to Optimal Management - John Stone, MD, MPH
11/07/2019 Duración: 38minDr. John Stone discusses best practices for integrating the latest clinical evidence surrounding new and emerging targeted therapies into optimal strategies for the long-term management of giant cell arteritis (GCA).
-
![Psoriasis: Translating Current and Emerging Therapies into Enhanced Management Strategies - Joel M. Gelfand, MD, MSCE]()
Psoriasis: Translating Current and Emerging Therapies into Enhanced Management Strategies - Joel M. Gelfand, MD, MSCE
11/07/2019 Duración: 37minDr. Joel M. Gelfand reviews the latest data regarding the pathogenesis of psoriasis (PsO) and the contribution of IL-23/Th17 signaling pathways to disease state, and discusses personalized treatment plans for patients with moderate-to-severe PsO that successfully incorporate both current and emerging therapies.
-
![Psoriasis: Optimizing Therapeutic Selection for Common Comorbidities and Special Patient Populations\ - Joel M. Gelfand, MD, MSCE]()
Psoriasis: Optimizing Therapeutic Selection for Common Comorbidities and Special Patient Populations\ - Joel M. Gelfand, MD, MSCE
11/07/2019 Duración: 11minThis webcast examines optimal therapies for concurrent psoriasis and comorbidity treatment while considering possible side effects and drug-drug interactions.
-
![Robotic Utilization in CLI: Protect Your Staff, Protect Yourself - Jihad Mustapha, MD]()
Robotic Utilization in CLI: Protect Your Staff, Protect Yourself - Jihad Mustapha, MD
05/06/2019 Duración: 56minThis webcast features a case presentation and expert panel discussion that focuses on the adoption of robotic-assisted peripheral interventions for complex CLI cases.
-
![Matthew J. Frigault, MD: Management of CRS and Neurotoxicity]()
Matthew J. Frigault, MD: Management of CRS and Neurotoxicity
30/04/2019 Duración: 16minWebcast: Keeping Up With CAR T-cell Therapies in B-Cell Lymphomas: Integrating Emerging Data into Therapeutic Decisions
-
![Caron A. Jacobson, MD, MMSc: CAR-T in Lymphoma]()
Caron A. Jacobson, MD, MMSc: CAR-T in Lymphoma
30/04/2019 Duración: 26minWebcast: Keeping Up With CAR T-cell Therapies in B-Cell Lymphomas: Integrating Emerging Data into Therapeutic Decisions
-
![Elizabeth Brem, MD: Update: Relapsed/Refractory Follicular Lymphoma]()
Elizabeth Brem, MD: Update: Relapsed/Refractory Follicular Lymphoma
30/04/2019 Duración: 19minWebcast: Persistent Challenges in the Management of Follicular Lymphoma: A Focus on P13K Inhibitors and Next-line Therapy
-
![John P. Leonard, MD: Update: Upfront and Maintenance Therapy in Follicular Lymphoma]()
John P. Leonard, MD: Update: Upfront and Maintenance Therapy in Follicular Lymphoma
30/04/2019 Duración: 21minWebcast: Persistent Challenges in the Management of Follicular Lymphoma: A Focus on P13K Inhibitors and Next-line Therapy
-
![Jasmine Zain, MD: Peripheral T-Cell Lymphoma: What is New on the Horizon?]()
Jasmine Zain, MD: Peripheral T-Cell Lymphoma: What is New on the Horizon?
30/04/2019 Duración: 27minWebcast: Confronting the Challenges of Peripheral T-Cell Lymphoma: Genomic Profiling and the Future Treatment Landscape
-
![Mojtaba Akhtari, MD: Case: A 54yo woman has been treated for AML and is in remission but MRD+]()
Mojtaba Akhtari, MD: Case: A 54yo woman has been treated for AML and is in remission but MRD+
30/04/2019 Duración: 19minWebcast: Looking to the Future With Hope: Advances in the Treatment of AML
-
![Daniel A. Pollyea, MD, MS: Update: New Drugs for AML]()
Daniel A. Pollyea, MD, MS: Update: New Drugs for AML
30/04/2019 Duración: 20minWebcast: Looking to the Future With Hope: Advances in the Treatment of AML
-
![Richard R. Furman, MD: Case on R/R High Risk CLL: Personalized Management Based on Patient Characteristics and Cytogenetics]()
Richard R. Furman, MD: Case on R/R High Risk CLL: Personalized Management Based on Patient Characteristics and Cytogenetics
30/04/2019 Duración: 20minWebcast: CLL in the Era of Targeted Therapy: Next Steps in Personalizing Management to Achieve Cure
